Invitation for Request for Expressions of Interest    Status:Approved

GOVERNMENT OF THE PEOPLE'S REPUBLIC OF BANGLADESH

Ministry/Division : Ministry of Health and Family Welfare
Agency : Directorate General of Health Services (DGHS)
Procuring Entity Name : Principal Investigator (PI), Integrated health science research and development fund activity project at BSMMU
Procuring Entity Code :
Procuring Entity District : Dhaka
Expression of Interest for Selection of : Consulting Firm (National)  (Lump-Sump)
Title Of Service : Suspected Adverse Drug Reaction - mobile app
EOI Ref. No. : BSMMU/PV/apps/2023/01
Date : 05/09/2023

KEY INFORMATION

Procurement Sub-Method : Single Source Selection (SSS)

FUNDING INFORMATION

Budget and Source of Funds : Development Budget GOB
Development Partners :

PARTICULAR INFORMATION

Project/Programme Name : Establishment of pharmacovigilance center project at BSMMU
EOI Closing Date and Time : 23/09/2023 03:00 PM
Publication Date : 13/09/2023

INFORMATION FOR APPLICANT

Brief Description of Assignment : The "Suspected Adverse Drug Reaction" mobile app is designed to address the need for a user-friendly platform that allows individuals to report and track suspected adverse reactions to medications. By facilitating the collection of valuable data on adverse drug reactions, the app aims to support healthcare professionals and regulatory authorities in monitoring and analyzing potential risks associated with medications. The Objective for the "Suspected Adverse Drug Reaction" mobile app encompasses the following objectives: Provide a User-Friendly Platform: Develop an intuitive and easy-to-use interface that enables users to report suspected adverse drug reactions with minimal effort. Enable Efficient Reporting: Implement functionality that allows users to provide relevant details, including medication information, symptoms, and patient demographics, to ensure comprehensive and accurate reporting. Track Reported Reactions: Create a system that allows users to track the status of their reported adverse drug reactions, providing updates on their progress and outcomes. Contribute to Data Collection: Facilitate the collection of comprehensive and reliable data on adverse drug reactions, which can be utilized for research, analysis, and decision-making by healthcare professionals and regulatory authorities. Enhance Drug Safety Monitoring: Support early detection and monitoring of potential risks associated with medications, improving patient safety and overall drug surveillance efforts. Promote User Engagement and Awareness: Encourage user engagement through features such as notifications, educational resources, and feedback mechanisms to enhance awareness and understanding of medication safety.
Experience, Resources and Delivery Capacity Required : 1. Experience in any similar work for any reputed organization. 2. Financial soundness of the firm; and Staffing and logistics of the firm. 3. Methodology and Work plan to execute the assignment in similar operating environments and conditions
Other Details (if applicable) : Not Applicable
Association with foreign firms is : Not Encouraged
Eoi Detail Information
Ref No Phasing Of Services Location Start Date Completion Date
- Not Phasing

PROCURING ENTITY DETAILS

Name of Official Inviting EOI : Dr. Elora Sharmin
Designation of Official Inviting EOI : Principal Investigator (PI), Integrated health science research and development fund activity project at BSMMU
Address of Official Inviting EOI : OPD-02, 10th floor, room no.1105,BSMMU , Shahbagh, Dhaka-1000
Contact details of Official Inviting EOI : Phone : 8801914499800, Fax : , Email : eloradoc@gmail.com
The procuring entity reserves the right to accept or reject all tenders